Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem.
about
Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infantsSafety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infectionsEpileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.Brain abscess: Current management.Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH)Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant Enterobacteriaceae.Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial.Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics.Meropenem-Induced Neutropenia in a Neonate.Management of neonatal sepsis by Gram-negative pathogens.Management of meningitis due to antibiotic-resistant Acinetobacter species.Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?Beta-lactam hypersensitivity and cross-reactivity.Antibiotic-induced neurotoxicity.Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review.The risk of seizures among the carbapenems: a meta-analysis.Safety of meropenem in patients reporting penicillin allergy: lack of allergic cross reactions.The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients - case reports and literature reviews.Outcome evaluation of an intervention to improve the effective and safe use of meropenem.Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.
P2860
Q24601509-C7D4F46E-65A5-47F5-B870-65849A9695CEQ24616863-ED09D936-3E0C-428F-AF81-B94A9DFEB39AQ34026343-609DA51D-B98A-4208-86B9-B470C095DE34Q34381475-E8223954-287C-40F8-86BC-F201CB565401Q35032863-B0E4A680-2539-4D38-BCD5-6C546DA7EF6FQ35979700-141FE9AC-4D36-4238-8E4A-C6DAE19D4442Q36633761-8FA7EB90-6A62-4633-8601-C27B208A48EDQ37149906-F37A7FA1-3E8F-4CC1-B09B-9DC3DCC045B2Q37292368-CFA3C13F-9272-42FB-BA15-BFD87C1B72E5Q37340565-BAFAA896-55A6-4581-91A7-826A2A607EECQ37382976-2F1A66E1-C7F6-44B6-A7D5-9309F9D8D588Q37385545-87C2CCDC-AE98-4454-9B22-F406B5784216Q38240001-2CBD55EB-D6D2-4512-99C3-56D693419FC4Q38263096-0CEA97B7-71BA-4FCA-982B-BE00F1CC117DQ38654209-032316E8-8A87-4403-91ED-4F52B926C9D1Q42218823-9C559333-904A-46E5-BA98-874B89F44370Q43994083-04D5C74D-6931-4430-AEE1-389DB7A4D3E5Q48156023-E46B03D9-74C7-495A-A3B7-646C11A203DFQ50696325-3C638ACC-7A22-4154-9313-66472451E127Q52683111-39AD6C7A-47E5-4E0E-9D84-C51B4E635937
P2860
Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Safety profile of meropenem: a ...... tients treated with meropenem.
@en
type
label
Safety profile of meropenem: a ...... tients treated with meropenem.
@en
prefLabel
Safety profile of meropenem: a ...... tients treated with meropenem.
@en
P1433
P1476
Safety profile of meropenem: a ...... tients treated with meropenem.
@en
P2093
Peter Linden
P304
P356
10.2165/00002018-200730080-00002
P577
2007-01-01T00:00:00Z
P6179
1043433296